Ab&B Bio-Tech (2627) has issued a proxy form for its second extraordinary general meeting of 2025, scheduled for December 23, 2025, at 10 a.m. in Taizhou, Jiangsu, PRC. According to the announcement, shareholders are allowed to appoint proxies to attend this meeting and vote on their behalf. The company emphasizes that any appointed proxy must attend in person and present valid identification.

The upcoming meeting will consider two ordinary resolutions: the proposed appointment of Mr. Li Jianjun as an independent non-executive director and the re-appointment of Deloitte Touche Tohmatsu as auditors for 2025. Shareholders who wish to vote on these matters should complete the proxy form accurately, indicating their instructions regarding each resolution.

The document outlines procedural requirements for submitting proxy forms, including the requirement for shareholders to lodge completed forms with the company's H share registrar, Tricor Investor Services Limited, at least 24 hours before the meeting time. The notice also specifies that if shareholders attend in person after submitting a proxy form, their proxy instructions will be deemed revoked. Additional details, such as joint shareholding arrangements and identity verification, can be found in the official circular accompanying the proxy form.